Shanghai Universal Biotech Co.,Ltd. distributes and supplies antibodies and protein products. The company offers antibodies, recombinant proteins, detection kits, antigens, and other products, as well as immunology reagents, molecular biology reagents, cell biology reagents and biochemical reagents, as well as reagent kits. It also provides technical services, technology promotion, technology information exchange, scientific and technology training, technology consulting, technology incubation and other services, as well as experimental services and software solutions. The company also sells products online. It serves colleges and universities, research institutes, hospitals, and biomedical companies. The company was founded in 2004 and is based in Shanghai, China.
Frequently asked questions
What sector does Shanghai Universal Biotech Co.Ltd. (301166) operate in?
Shanghai Universal Biotech Co.Ltd. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Shanghai Universal Biotech Co.Ltd. (301166) current stock price?
As of the latest data, Shanghai Universal Biotech Co.Ltd. stock price is CN¥29.08, with a previous close of CN¥28.75. Shanghai Universal Biotech Co.Ltd. gained CN¥0.33 in the last trading session, representing a 1.15% increase.
What is Shanghai Universal Biotech Co.Ltd. (301166) current market capitalization?
Shanghai Universal Biotech Co.Ltd. market cap is approximately 2.51 billion.
What is Shanghai Universal Biotech Co.Ltd. (301166) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.29.
Does Shanghai Universal Biotech Co.Ltd. (301166) pay dividends?
Yes. Shanghai Universal Biotech Co.Ltd. pays annual dividends with an annualized yield of 2.06% and an estimated annual payout of CN¥0.60 per share.
When is the next ex-dividend date for Shanghai Universal Biotech Co.Ltd. (301166)?
The next ex-dividend date is scheduled for June 01, 2027.
What is Shanghai Universal Biotech Co.Ltd. (301166) beta (volatility) score?
Shanghai Universal Biotech Co.Ltd. has a beta of 1.042, meaning its volatility is roughly in line with the market.